Nicotinamide adenine dinucleotide (NAD+) is not a peptide — it's a coenzyme found in every living cell. But its role in aging biology is so central that it's become one of the most researched molecules in the longevity space, sitting alongside peptides like SS-31, MOTS-c, and Epitalon in anti-aging protocols.
Research-context information only. NAD+ is a research peptide. Protocols, doses, and reactions reported below come from published research and self-reported community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.
NAD+ levels decline approximately 50% between ages 40 and 60 (Massudi et al., 2012). This decline impairs mitochondrial energy production, DNA repair, sirtuin activity, and hundreds of other enzymatic reactions. Restoring NAD+ levels — through direct supplementation or precursors — is one of the most active areas of longevity research.
This guide covers what the published data actually shows. Every benefit is linked to a study. No miracle claims.
Table of Contents
- What Is NAD+ and Why Does It Decline?
- Research Benefits Overview
- Mitochondrial Energy Production
- DNA Repair and Genomic Stability
- Sirtuin Activation and Longevity Signaling
- Neuroprotection and Cognitive Function
- Cardiovascular Health
- Metabolic Health and Insulin Sensitivity
- Stem Cell Rejuvenation
- Exercise Performance and Recovery
- What NAD+ Does NOT Do
- Frequently Asked Questions
- References
What Is NAD+ and Why Does It Decline?
NAD+ is a coenzyme required for over 500 enzymatic reactions in human cells. It exists in two forms — NAD+ (oxidized) and NADH (reduced) — and shuttles electrons in metabolic reactions that produce cellular energy. Without NAD+, mitochondria cannot generate ATP, and cells cannot function.
NAD+ is also a substrate consumed by three families of enzymes critical to cellular health:
- Sirtuins (SIRT1-7) — deacetylases that regulate gene expression, DNA repair, inflammation, and mitochondrial biogenesis. They consume NAD+ with every reaction (Imai & Guarente, 2014).
- PARPs (poly ADP-ribose polymerases) — DNA repair enzymes that use NAD+ to fix strand breaks. PARP1 is the primary consumer of cellular NAD+ during DNA damage (Fang et al., 2017).
- CD38 — an NADase whose expression increases with aging, actively degrading NAD+. CD38 is now considered a major driver of age-related NAD+ decline (Camacho-Pereira et al., 2016).
The problem: as we age, NAD+ synthesis slows down while consumption accelerates. CD38 activity increases, PARP activity increases (more DNA damage to repair), and the salvage pathway enzyme NAMPT declines. The result is a progressive NAD+ deficit that compromises cellular function across every organ system.
For dosing protocols across all administration routes, see our NAD+ Dosing Guide.
Research Benefits Overview
| Research Area | Key Finding | Primary Source |
|---|---|---|
| Mitochondrial energy | NAD+ is essential electron carrier in ETC; decline impairs ATP output | Stein & Imai, 2012 |
| DNA repair | NAD+ fuels PARP enzymes; replenishment restores repair capacity | Fang et al., 2017 |
| Sirtuin activation | NAD+ is mandatory substrate for SIRT1-7 longevity pathways | Imai & Guarente, 2014 |
| Neuroprotection | NAD+ decline drives neurodegeneration; supplementation is protective | Lautrup et al., 2019 |
| Cardiovascular | NMN protects heart from ischemia-reperfusion injury | Yamamoto et al., 2014 |
| Insulin sensitivity | 250mg/day NMN improved muscle insulin sensitivity in humans | Yoshino et al., 2021 |
| Stem cells | NR rejuvenated aged muscle stem cells and extended lifespan in mice | Zhang et al., 2016 |
| Exercise capacity | NMN improved aerobic capacity in amateur runners (dose-dependent) | Liao et al., 2021 |
Mitochondrial Energy Production
Mitochondria produce 90% of cellular energy (ATP) through oxidative phosphorylation. NAD+ is a critical electron carrier in this process — it accepts electrons from nutrients in the Krebs cycle (becoming NADH), then donates them to Complex I of the electron transport chain (ETC), driving ATP synthesis.
When NAD+ levels drop, the ETC slows down. Cells produce less ATP, generate more reactive oxygen species (ROS), and shift toward less efficient glycolytic energy production. This is why fatigue is one of the earliest subjective symptoms of aging — your cells literally produce less energy.
Stein & Imai (2012) demonstrated that declining NAD+ directly impairs mitochondrial function in aged tissues. Restoring NAD+ levels improved mitochondrial membrane potential, increased ETC efficiency, and reduced oxidative stress in preclinical models (Stein & Imai, 2012).
NAD+ also regulates mitochondrial biogenesis through SIRT1 activation of PGC-1α, the master regulator of new mitochondria creation. More NAD+ means more SIRT1 activity, which means more PGC-1α, which means more mitochondria. This is the biochemical basis for the energy improvements reported by NAD+ users.
For a complementary approach targeting the mitochondrial membrane itself, see SS-31 — it stabilizes cardiolipin while NAD+ fuels the ETC that cardiolipin organizes.
DNA Repair and Genomic Stability
Every cell in your body sustains tens of thousands of DNA lesions daily — from oxidative stress, UV radiation, metabolic byproducts, and replication errors. PARP enzymes (primarily PARP1) detect these breaks and orchestrate repair, consuming NAD+ as fuel for every repair event.
The problem with aging: DNA damage accumulates while NAD+ declines. PARP1 competes with sirtuins for a shrinking NAD+ pool. When NAD+ is scarce, DNA repair suffers, and unrepaired damage leads to mutations, cellular senescence, and cancer risk.
Fang et al. (2017) showed that NAD+ replenishment restored PARP-mediated DNA repair capacity in aged cells and animal models. Supplementation with NMN or NR improved genomic stability, reduced accumulation of DNA damage markers, and improved outcomes in models of accelerated aging (Fang et al., 2017).
This competition between PARPs and sirtuins for NAD+ is one of the key mechanisms of aging. When NAD+ is abundant, both systems function well. When it's depleted, your body must choose between repairing DNA and maintaining the gene regulatory functions that sirtuins control. Restoring NAD+ levels resolves this zero-sum competition.
Sirtuin Activation and Longevity Signaling
Sirtuins (SIRT1-7) are often called "longevity genes" because their activity correlates with lifespan across species — from yeast to mice to primates. They are NAD+-dependent deacetylases, meaning they literally cannot function without NAD+ as a co-substrate.
Each sirtuin has a distinct role:
- SIRT1 — nuclear; regulates gene expression, DNA repair, inflammation, and mitochondrial biogenesis via PGC-1α
- SIRT2 — cytoplasmic; cell cycle regulation, genome stability
- SIRT3 — mitochondrial; directs mitochondrial metabolism, fatty acid oxidation, antioxidant defenses
- SIRT4 — mitochondrial; regulates amino acid metabolism and insulin secretion
- SIRT5 — mitochondrial; modulates urea cycle and fatty acid metabolism
- SIRT6 — nuclear; telomere maintenance, DNA repair, glucose homeostasis
- SIRT7 — nucleolar; ribosome biogenesis, stress response
Imai & Guarente (2014) established that age-related NAD+ decline is the primary cause of reduced sirtuin activity in aging tissues. Restoring NAD+ levels reactivated sirtuin function and ameliorated age-associated pathologies in multiple organ systems (Imai & Guarente, 2014).
The caloric restriction connection: caloric restriction — the only intervention consistently shown to extend lifespan across species — works partly by increasing NAD+ levels and sirtuin activity. NAD+ supplementation mimics some of the molecular effects of caloric restriction without the actual calorie reduction.
Neuroprotection and Cognitive Function
The brain consumes roughly 20% of the body's total energy despite being only 2% of body mass. This extreme metabolic demand makes neurons especially vulnerable to NAD+ decline.
Lautrup et al. (2019) published a comprehensive review showing that NAD+ depletion drives neuronal dysfunction through multiple converging mechanisms: impaired mitochondrial energy production in neurons, compromised DNA repair in post-mitotic cells (neurons can't divide to replace damaged ones), reduced SIRT1-mediated neuroprotection, and impaired autophagy/mitophagy (the recycling systems that clear damaged cellular components) (Lautrup et al., 2019).
In preclinical models, NAD+ supplementation through NMN or NR:
- Reduced neuroinflammation and microglial activation
- Improved mitochondrial function in aged neurons
- Protected against amyloid-beta toxicity (Alzheimer's model)
- Preserved synaptic plasticity and cognitive performance in aged mice
- Reduced axonal degeneration following injury
NAD+ also regulates the circadian clock through NAMPT-mediated biosynthesis oscillations (Ramsey et al., 2009). Disrupted NAD+ rhythms impair sleep-wake cycles, which themselves are critical for brain health and cognitive function.
Human cognitive data for NAD+ supplementation is limited but emerging. The mechanistic basis is strong, and multiple trials are currently enrolling.
Ready to buy? Compare verified vendors on our best NAD+ sources page, or browse all coupon codes for up to 50% off.
